{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:05:32Z","timestamp":1787864732187,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jdiacomp.2025.109087","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T12:13:51Z","timestamp":1747829631000},"page":"109087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study)"],"prefix":"10.1016","volume":"39","author":[{"given":"Nikolaos","family":"Papanas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Tsimihodimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Katsiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Doupis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Pagkalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Nikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Papakonstantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Karpouzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tentolouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109087_bb0005","series-title":"IDF diabetes atlas, 10th edn","author":"Magliano","year":"2021"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.diabres.2016.06.018","article-title":"The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database","volume":"118","author":"Liatis","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0015","article-title":"Hellenic national health examination survey (H-NHES) 2019-2021","volume":"70","author":"Makrilakis","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0020","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12933-021-01408-1","article-title":"Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management","volume":"20","author":"Ceriello","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10741-022-10238-6","article-title":"Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence","volume":"28","author":"Palazzuoli","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0040","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3390\/jcm10163682","article-title":"Diabetes mellitus and heart failure","volume":"10","author":"Triposkiadis","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/dme.13915","article-title":"Heart failure among people with type 2 diabetes mellitus: real-world data of 289 954 people from a diabetes database","volume":"37","author":"Stoyanova","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0050","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1080\/14656566.2022.2143263","article-title":"Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes","volume":"23","author":"Katsiki","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0055","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065927","article-title":"Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the clinical practice research datalink","volume":"13","author":"Cook","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0070","first-page":"322","article-title":"SGLT2 inhibitors vs. glp-1 agonists to treat the heart, the kidneys and the brain","volume":"10","author":"Rolek","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0075","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0080","article-title":"American Diabetes Association professional practice committee. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0085","series-title":"Guidelines for the management of the diabetic patient","author":"Hellenic Diabetes Association (HDA)","year":"2023"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0090","series-title":"Guidelines for the management of the diabetic patient","author":"Hellenic Diabetes Association (HDA)","year":"2020"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0095","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"Kdigo 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","author":"Kidney Disease: Improving global outcomes (KDIGO) diabetes work group","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0100","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s13300-019-00698-9","article-title":"Prevalence of established cardiovascular disease in patients with type 2 diabetes mellitus in the UK","volume":"10","author":"Lautsch","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.76","article-title":"The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States","volume":"2","author":"Weng","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-020-0496-7","article-title":"Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry","volume":"20","author":"Souliotis","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1055\/a-1508-3912","article-title":"Prevalence of atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease in patients with type 2 diabetes mellitus: a primary care research network-based study","volume":"130","author":"Goderis","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12933-021-01344-0","article-title":"CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries","volume":"20","author":"Mosenzon","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.810757","article-title":"Trends in the degree of control and treatment of cardiovascular risk factors in people with type 2 diabetes in a primary care setting in Catalonia during 2007\u20132018","volume":"12","author":"Mata-Cases","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/circ.148.suppl_1.11760","article-title":"Abstract 11760: prevalence of atherosclerosis, heart failure, and chronic kidney disease among patients with type 2 diabetes and management with diabetes pharmacotherapy","volume":"148","author":"Mohl","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0135","article-title":"Underprescription of SGLT2i and GLP-1 RA: CAREPRO-T2D (Cardiorenal protection in type 2 diabetes) cross-sectional study","volume":"15","author":"Sim\u00f5es de Carvalho","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.diabet.2012.08.004","article-title":"Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007)","volume":"38","author":"Assogba","year":"2012","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/dme.12312","article-title":"Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit","volume":"31","author":"Hill","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-7-415","article-title":"Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on kidney disease: improving global outcomes (KDIGO) staging","volume":"7","author":"Bailey","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0155","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3390\/jcm10132886","article-title":"Prevalence of chronic kidney disease in patients with diabetes in Extremadura (Spain) during the years 2012, 2013 and 2014: an observational study","volume":"10","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pcd.2020.11.015","article-title":"Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain)","volume":"15","author":"Calvo-Hueros","year":"2021","journal-title":"An observational study Prim Care Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002125","article-title":"Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in northern Europe","volume":"9","author":"Griffin","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108243","article-title":"The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: a series from hospital-based diabetes clinics","volume":"166","author":"Migdalis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4239\/wjd.v6.i1.208","article-title":"Glycaemic control, treatment satisfaction and quality of life in type 2 diabetes patients in Greece: the PANORAMA study Greek results","volume":"6","author":"Avramopoulos","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-0043-109242","article-title":"The real-life effectiveness and care patterns of type 2 diabetes management in Greece","volume":"126","author":"Pagkalos","year":"2018","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12902-019-0364-5","article-title":"A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies","volume":"19","author":"Liatis","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0190","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s13300-020-00935-6","article-title":"Adherence to the national guidelines for follow-up protocol in subjects with type 2 diabetes mellitus in Greece: the GLANCE study","volume":"11","author":"Papanas","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0195","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1590\/0004-2730000003223","article-title":"Obesity, insulin resistance and comorbidities? Mechanisms of association","volume":"58","author":"Castro","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0200","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002495","article-title":"Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis","volume":"5","author":"Wahid","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000185","article-title":"Physical activity, sedentary behaviors and the incidence of type 2 diabetes mellitus: the multi-ethnic study of atherosclerosis (MESA)","volume":"4","author":"Joseph","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0210","doi-asserted-by":"crossref","first-page":"1227769","DOI":"10.3389\/fcvm.2023.1227769","article-title":"Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines","volume":"10","author":"Gourdy","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0215","first-page":"1","article-title":"Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile","volume":"13","author":"Scheen","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0220","article-title":"Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk","volume":"13","author":"Scheen","year":"2023","journal-title":"Diabet Epidemiol Manag"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0225","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ejhf.2971","article-title":"Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry","volume":"25","author":"Stolfo","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jdiacomp.2025.109087_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:05:48Z","timestamp":1762362348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725001400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1056872725001400"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109087","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study)","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109087"}}